Balsam Al-Ufuq Medical Company, commercially known as “Balsam Medical,” announced the signing of a significant contract with the Royal Commission in Jubail, valued at SAR 71.8 million. Under this five-year contract, the company will be responsible for the operation and maintenance of primary healthcare services within the Ras Al-Khair project in Jubail Industrial City, a move that reflects confidence in the company’s capabilities and expertise in the healthcare sector.
Historical background and strategic context
Established in 1975, the Royal Commission for Jubail and Yanbu is the driving force behind the development and management of industrial cities in Saudi Arabia. Under its management, Jubail Industrial City has transformed into one of the world’s largest industrial and petrochemical complexes. The Commission’s role extends beyond the industrial sector to include the development of integrated infrastructure and high-quality community services, including education, housing, and healthcare, with the aim of creating an attractive environment for investors and a skilled workforce. This contract is part of the Commission’s ongoing efforts to ensure the provision of world-class healthcare services to the residents and workforce in its vital industrial areas.
Project importance and expected impact
This project is of particular importance as it focuses on primary healthcare, which is the first line of defense in any effective healthcare system. By providing high-quality, essential preventive and curative services in the Ras Al-Khair area, the project contributes to improving the overall health of workers and their families, positively impacting productivity and social stability in this promising industrial region. This approach aligns directly with the goals of Saudi Vision 2030, specifically the Health Sector Transformation Program, which aims to enhance the quality and efficiency of healthcare services and strengthen the role of the private sector as a strategic partner in development.
Financial impact and economic repercussions
Financially, Balsam Medical expects the positive impact of the contract to begin appearing in its financial results during the first half of 2026, bolstering its financial stability and future growth. More broadly, this contract represents a successful public-private partnership (PPP) model, an approach encouraged by the Saudi government to accelerate the development of public services and leverage the expertise and efficiency of the private sector. The contract also enhances the competitiveness of the Saudi healthcare sector and highlights the significant investment opportunities available, potentially attracting further local and foreign investment to this vital sector.
